Literature DB >> 21455670

Genetic variation in genes encoding for polymerase ζ subunits associates with breast cancer risk, tumour characteristics and survival.

Verena Varadi1, Melanie Bevier, Ewa Grzybowska, Robert Johansson, Kerstin Enquist, Roger Henriksson, Dorota Butkiewicz, Jolanta Pamula-Pilat, Karolina Tecza, Kari Hemminki, Per Lenner, Asta Försti.   

Abstract

Chromosomal instability is a known hallmark of many cancers. DNA polymerases represent a group of enzymes that are involved in the mechanism of chromosomal instability as they have a central function in DNA metabolism. We hypothesized that genetic variation in the polymerase genes may affect gene expression or protein configuration and by that cancer risk and clinical outcome. We selected four genes encoding for the catalytic subunits of the polymerases β, δ, θ and ζ (POLB, POLD1, POLQ and REV3L, respectively) and two associated proteins (MAD2L2 and REV1) because of their previously reported association with chromosomal instability and/or tumorigenesis. We selected potentially functional and most informative tagging single nucleotide polymorphisms (SNPs) for genotyping in a population-based series of 783 Swedish breast cancer (BC) cases and 1562 controls. SNPs that showed a significant association in the Swedish population were additionally genotyped in a Polish population consisting of 506 familial/early onset BC cases and 568 controls. SNPs in all three polymerase ζ subunit genes associated either with BC risk or prognosis. Two SNPs in REV3L and one SNP in MAD2L2 associated with BC risk: rs462779 (multiplicative model: OR 0.79, 95% CI 0.68-0.92), rs3204953 (dominant model: OR 1.28, 95% CI 1.05-1.56) and rs2233004 (recessive model: OR 0.49, 95% CI 0.28-0.86). Homozygous carriers of the minor allele C of the third SNP in REV3L, rs11153292, had significantly worse survival compared to the TT genotype carriers (HR 2.93, 95% CI 1.34-6.44). Minor allele carriers of two REV1 SNPs (rs6761391 and rs3792142) had significantly more often large tumours and tumours with high histological grade and stage. No association was observed for SNPs in POLB, POLQ and POLD1. Altogether, our data suggest a significant role of genetic variation in the polymerase ζ subunit genes regarding the development and progression of BC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21455670     DOI: 10.1007/s10549-011-1460-z

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  20 in total

1.  Multiple functional linear model for association analysis of RNA-seq with imaging.

Authors:  Junhai Jiang; Nan Lin; Shicheng Guo; Jinyun Chen; Momiao Xiong
Journal:  Quant Biol       Date:  2015-08-15

2.  Translesion polymerase genes polymorphisms and haplotypes influence survival of osteosarcoma patients.

Authors:  Katja Goričar; Viljem Kovač; Janez Jazbec; Branko Zakotnik; Janez Lamovec; Vita Dolžan
Journal:  OMICS       Date:  2015-03

3.  Linking DNA polymerase theta structure and function in health and disease.

Authors:  Kelly Beagan; Mitch McVey
Journal:  Cell Mol Life Sci       Date:  2015-10-29       Impact factor: 9.261

4.  The relationship between eight GWAS-identified single-nucleotide polymorphisms and primary breast cancer outcomes.

Authors:  Soley Bayraktar; Patricia A Thompson; Suk-Young Yoo; Kim-anh Do; Aysegul A Sahin; Banu K Arun; Melissa L Bondy; Abenaa M Brewster
Journal:  Oncologist       Date:  2013-05-01

Review 5.  Biological and therapeutic relevance of nonreplicative DNA polymerases to cancer.

Authors:  Jason L Parsons; Nils H Nicolay; Ricky A Sharma
Journal:  Antioxid Redox Signal       Date:  2012-09-05       Impact factor: 8.401

Review 6.  DNA polymerases in the mitochondria: A critical review of the evidence.

Authors:  Rachel Krasich; William C Copeland
Journal:  Front Biosci (Landmark Ed)       Date:  2017-01-01

7.  Excavating the pathogenic gene of breast cancer based on high throughput data of tumor and somatic reprogramming.

Authors:  Lian Duan; Zhendong Wang; Xin Zheng; Junjian Li; Huamin Yin; Weibo Tang; Dejian Deng; Hui Liu; Jiayu Wei; Yan Jin; Feng Liu; Jingling Shen
Journal:  Cell Cycle       Date:  2021-08-13       Impact factor: 5.173

8.  REV3L, a promising target in regulating the chemosensitivity of cervical cancer cells.

Authors:  Li Yang; Tingyan Shi; Fei Liu; Chunxia Ren; Ziliang Wang; Yingyi Li; Xiaoyu Tu; Gong Yang; Xi Cheng
Journal:  PLoS One       Date:  2015-03-17       Impact factor: 3.240

9.  Human REV3 DNA Polymerase Zeta Localizes to Mitochondria and Protects the Mitochondrial Genome.

Authors:  Bhupendra Singh; Xiurong Li; Kjerstin M Owens; Ayyasamy Vanniarajan; Ping Liang; Keshav K Singh
Journal:  PLoS One       Date:  2015-10-13       Impact factor: 3.240

10.  Association of germline variation in CCNE1 and CDK2 with breast cancer risk, progression and survival among Chinese Han women.

Authors:  Ji-Yuan Han; Hui Wang; Yun-Tao Xie; Yan Li; Li-Yuan Zheng; Yuan Ruan; Ai-Ping Song; Xin-Xia Tian; Wei-Gang Fang
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.